4548.T
SEIKAGAKU CORPORATION
プライム · 医薬品 · 医薬品 · JP
JPY 705.00
−0.14%Year over year
Reported trailing growth
- Revenue
- -6.9%
- EBITDA
- —
- EBIT
- —
- EPS
- +21.2%
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- -0.7%
- EBITDA
- —
- EPS
- -38.9%
Three-year CAGR
- Revenue
- +3.1%
- EBITDA
- -26.0%
- EBIT
- —
- Net income
- -13.0%
- EPS
- -12.6%
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026